Engimmune Therapautics
Start-up
Hegenheimermattweg 167A, 4123 Allschwil, Switzerland
Biotech
Web-Technology
Platform for generating the T-cell receptor on the surface of T-cells with high throughput. Can accurately predict off-target antigens and develop synthetic TCRs for increased effectiveness and specificity. Leads for MAGE-A3 (tumor antigen) with high potency and specificity
Become a member of
BaselTech COMMUNITY
Connect with people who drive ideas forward: Experts, start-ups and established companies from the Basel region. Share knowledge, find solutions and shape the future together.